HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19-Reference-Cited by-同舟云学术

HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19

Published:2020-05-19 Issue:47 Volume:5 Page:
ISSN:2470-9468
Container-title:Science Immunology
language:en
Short-container-title:Sci. Immunol.

Author:

Spinelli Francesca Romana¹,Conti Fabrizio¹^ORCID,Gadina Massimo²

Affiliation:

1. Sapienza Università di Roma, Dipartimento di Scienze Cliniche, Internistiche, Anestesiologiche e Cardiovascolari—Reumatologia, Rome, Italy.

2. Translational Immunology Section, Office of Science and Technology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD, USA.

Abstract

JAK kinase inhibitors are being investigated as a way of managing cytokine storm in patients with severe COVID-19.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine,Immunology

Reference10 articles.

1. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19;Cheng H.;J. Med. Virol.,2020

2. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

3. Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients;Hadjadj J.;medRxiv,2020

4. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome

5. Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19;Sciascia S.;Clin. Exp. Rheumatol.,2020

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes of immunomodulation therapy in immunocompromised patients with severe Covid-19 and high oxygen requirement;Scientific Reports;2024-07-23

2. CXCR6+CD69+ CD8+ T cells in ascites are associated with disease severity in patients with cirrhosis;JHEP Reports;2024-06

3. Network Pharmacology and Experimental Validation of Qingwen Baidu Decoction Therapeutic Potential in COVID-19-related Lung Injury;Combinatorial Chemistry & High Throughput Screening;2023-11-10

4. Immunosenescence and Inflammaging in COVID-19;Viral Immunology;2023-11-01

5. CXCR1 drives the pathogenesis of EAE and ARDS via boosting dendritic cells-dependent inflammation;Cell Death & Disease;2023-09-14